SCHEMBL8057442

SCHEMBL8057442

CCC(C)(C)c1ccncc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44
MAPT P10636 1/20 0.44
HRH3 Q9Y5N1 4/20 0.43
KIF11 P52732 2/20 0.43
HDAC8 Q9BY41 1/20 0.38
LMNA P02545 1/20 0.37
MAPK1 P28482 1/20 0.37
CASP3 P42574 1/20 0.37
ATM Q13315 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
CNR2 P34972 2/20 0.36
USP2 O75604 1/20 0.35
CYP19A1 P11511 1/20 0.35
MAOB P27338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13889346 0.87 KIF11 (0.63) RAB9ANPC1MAPTHRH3KIF11
SCHEMBL18470613 0.81 KIF11 (0.40) RAB9AHRH3KIF11HDAC8CNR2
SCHEMBL779443 0.81 NPC1 (0.58) RAB9ANPC1MAPTHRH3LMNA
SCHEMBL13194993 0.80 KIF11 (0.43) RAB9AMAPTKIF11LMNASMN1; SMN2
SCHEMBL18682641 0.78 SHBG (0.56) RAB9AKIF11HDAC8LMNASMN1; SMN2
SCHEMBL22317811 0.78 HDAC8 (0.42) RAB9AMAPTKIF11HDAC8LMNA
SCHEMBL10487429 0.78 KIF11 (0.41) RAB9AKIF11HDAC8CNR2USP2
SCHEMBL16455578 0.78 KIF11 (0.41) RAB9AMAPTKIF11HDAC8LMNA
SCHEMBL8744330 0.78 TAAR1 (0.60) RAB9AMAPTKIF11HDAC8LMNA
SCHEMBL21943449 0.78 CNR2 (0.45) KIF11CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043613-B2 Inhibitors of SARM1 DISARM THERAPEUTICS, INC. (US) 2024-07-23 US disclosed
US-11912685-B2 Biphenyl diaryl pyrimidine derivative with aromatic heterocyclic structure FUDAN UNIVERSITY (CN) 2024-02-27 US disclosed
US-20240018157-A1 CYCLIC COMPOUNDS AND METHODS OF USING SAME SCHRÖDINGER, INC. 2024-01-18 US disclosed
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-11744906-B2 Compositions, methods, and systems for the synthesis and use of imaging agents LANTHEUS MEDICAL IMAGING, INC. (US) 2023-09-05 US disclosed
US-11746100-B2 Cycloalkyl pyrimidines as ferroportin inhibitors GLOBAL BLOOD THERAPEUTICS, INC. (US) 2023-09-05 US disclosed
US-11724992-B2 Compounds and compositions for treating conditions associated with NLRP activity NOVARTIS AG (CH) 2023-08-15 US disclosed
US-11709427-B2 Positive resist composition and pattern forming process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-07-25 US disclosed
US-11709427-B2 Positive resist composition and pattern forming process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-07-25 US disclosed
US-20230210853-A1 TARGETED NEK7 INHIBITION FOR MODULATION OF THE NLRP3 INFLAMMASOME Halia Therapeutics, Inc. 2023-07-06 US disclosed
US-8741537-B2 Positive resist composition and pattern-forming method using the same FUJIFILM CORPORATION (JP) 2014-06-03 US disclosed
US-8663880-B2 Polymerizable composition for color filter, color filter, and solid-state imaging device FUJIFILM CORPORATION (JP) 2014-03-04 US disclosed
US-20130078426-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM, PATTERN FORMING METHOD, METHOD FOR PREPARING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE, EACH USING THE SAME FUJIFILM CORPORATION (JP) 2013-03-28 US disclosed
US-20120282548-A1 PATTERN FORMING METHOD, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND RESIST FILM FUJIFILM CORPORATION (JP) 2012-11-08 US disclosed
US-20110217637-A1 POLYMERIZABLE COMPOSITION FOR COLOR FILTER, COLOR FILTER, AND SOLID-STATE IMAGING DEVICE FUJIFILM CORPORATION (JP) 2011-09-08 US disclosed
US-20100247938-A1 MATERIAL FOR THREE-DIMENSIONAL MODELING, PROCESS FOR PRODUCING THREE-DIMENSIONAL MODEL, AND THREE-DIMENSIONAL MODEL FUJIFILM CORPORATION (JP) 2010-09-30 US disclosed
US-7592392-B2 Synthesis of functional polymers for use in organic synthesis and combinatorial chemistry MERCK & CO. INC. (US) 2009-09-22 US disclosed
US-7592392-B2 Synthesis of functional polymers for use in organic synthesis and combinatorial chemistry MERCK & CO. INC. (US) 2009-09-22 US disclosed
WO-2009050248-A1 SUBSTITUTED PIPERIDINO-DIHYDROTHIENOPYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-23 WO disclosed
WO-2007022258-A1 NOVEL HIGH AFFINITY THIOPHENE-BASED AND FURAN-BASED KINASE LIGANDS SCHERING CORPORATION (US) 2007-02-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11709427-B2 Positive resist composition and pattern forming process EWSR1, PARG, VIM RAB9A 1736/4885NPC1 4499/4885MAPT 3107/4885
US-20230210853-A1 TARGETED NEK7 INHIBITION FOR MODULATION OF THE NLRP3 INFLAMMASOME NEK7, NLRP3, NOD1 RAB9A 3477/4885NPC1 348/4885MAPT 436/4885
US-11746100-B2 Cycloalkyl pyrimidines as ferroportin inhibitors HAMP, SLC40A1, FANCI RAB9A 2831/4885NPC1 389/4885MAPT 4441/4885
US-11912685-B2 Biphenyl diaryl pyrimidine derivative with aromatic heterocyclic structure DPYD, TYMP, DHODH RAB9A 2218/4885NPC1 647/4885MAPT 1065/4885
US-12043613-B2 Inhibitors of SARM1 SARM1, SMN1; SMN2, SARNP RAB9A 752/4885NPC1 232/4885MAPT 89/4885
US-11724992-B2 Compounds and compositions for treating conditions associated with NLRP activity NLRP1, NLRP3, NOD1 RAB9A 2131/4885NPC1 55/4885MAPT 2020/4885
US-11744906-B2 Compositions, methods, and systems for the synthesis and use of imaging agents FABP3, TNNI3, TNNT2 RAB9A 2539/4885NPC1 221/4885MAPT 752/4885
US-20120282548-A1 PATTERN FORMING METHOD, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND RESIST FILM RAD51, RER1, RXRA RAB9A 647/4885NPC1 3490/4885MAPT 451/4885
US-20240018157-A1 CYCLIC COMPOUNDS AND METHODS OF USING SAME MALT1, FKBP1B, FKBP1A RAB9A 1554/4885NPC1 445/4885MAPT 3951/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP RAB9A 936/4885NPC1 868/4885MAPT 2516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.